US Stock MarketDetailed Quotes
BLPH Bellerophon Therapeutics
- 0.055
- 0.0000.00%
15min DelayClose Nov 21 16:00 ET
672.80KMarket Cap-61P/E (TTM)
0.000High0.000Low5Volume0.038Open0.055Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)12.23MShares0.10052wk High0.18P/B654.87KFloat Cap0.03052wk Low--Dividend TTM11.91MShs Float193.800Historical High--Div YieldTTM0.00%Amplitude0.029Historical Low0.000Avg Price1Lot Size
Bellerophon Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -61.28%4.38M | -35.23%10.58M | -24.14%15.17M | -72.01%6.92M | -72.01%6.92M | -60.59%11.32M | -52.40%16.33M | -49.59%20M | -47.99%24.74M | -47.99%24.74M |
| -Cash and cash equivalents | -61.28%4.38M | -35.23%10.58M | -24.14%15.17M | -72.01%6.92M | -72.01%6.92M | -60.59%11.32M | -52.40%16.33M | -49.59%20M | -47.99%24.74M | -47.99%24.74M |
| Restricted cash | -73.27%108K | -73.45%107K | 293.20%405K | 293.20%405K | 293.20%405K | 292.23%404K | 291.26%403K | 0.00%103K | 0.00%103K | 0.00%103K |
| Other current assets | 44.67%489K | 119.07%563K | -53.03%194K | -62.26%234K | -62.26%234K | -62.36%338K | -71.12%257K | -7.40%413K | 47.62%620K | 47.62%620K |
| Total current assets | -58.71%4.98M | -33.81%11.25M | -23.13%15.77M | -70.29%7.56M | -70.29%7.56M | -59.42%12.06M | -51.87%16.99M | -48.99%20.52M | -47.05%25.46M | -47.05%25.46M |
| Non current assets | ||||||||||
| Net PPE | --0 | --0 | -98.79%9K | -80.00%186K | -80.00%186K | -67.41%363K | -57.23%556K | -50.03%743K | -44.41%930K | -44.41%930K |
| -Gross PPE | --0 | --0 | -98.79%9K | -20.02%2.71M | -20.02%2.71M | -67.41%363K | -57.23%556K | -50.03%743K | -15.90%3.39M | -15.90%3.39M |
| -Accumulated depreciation | ---- | ---- | ---- | -2.64%-2.53M | -2.64%-2.53M | ---- | ---- | ---- | -4.32%-2.46M | -4.32%-2.46M |
| Other non current assets | ---- | ---- | -61.73%186K | -61.73%186K | -61.73%186K | -61.73%186K | -61.73%186K | 0.00%486K | 0.00%486K | 0.00%486K |
| Total non current assets | --0 | --0 | -84.13%195K | -73.73%372K | -73.73%372K | -65.69%549K | -58.45%742K | -37.71%1.23M | -34.41%1.42M | -34.41%1.42M |
| Total assets | -60.51%4.98M | -36.58%11.25M | -26.58%15.97M | -70.47%7.94M | -70.47%7.94M | -59.74%12.61M | -52.18%17.73M | -48.46%21.75M | -46.51%26.88M | -46.51%26.88M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -59.87%612K | -5.98%1.89M | -51.21%1.07M | 3.19%1.23M | 3.19%1.23M | 19.33%1.53M | -19.20%2.01M | -42.41%2.19M | -68.00%1.19M | -68.00%1.19M |
| -accounts payable | -59.87%612K | -5.98%1.89M | -51.21%1.07M | 3.19%1.23M | 3.19%1.23M | 19.33%1.53M | -19.20%2.01M | -42.41%2.19M | -68.00%1.19M | -68.00%1.19M |
| Current accrued expenses | -80.23%644K | 30.78%3.74M | 64.34%4.29M | 27.67%3.97M | 27.67%3.97M | 4.79%3.26M | -5.31%2.86M | -26.80%2.61M | -48.23%3.11M | -48.23%3.11M |
| Current debt and capital lease obligation | ---- | ---- | -98.95%8K | -73.01%203K | -73.01%203K | -46.49%396K | -19.51%586K | 6.84%765K | 6.82%752K | 6.82%752K |
| -Current capital lease obligation | --0 | --0 | -98.95%8K | -73.01%203K | -73.01%203K | -46.49%396K | -19.51%586K | 6.84%765K | 6.82%752K | 6.82%752K |
| Current liabilities | -75.75%1.26M | 3.17%5.62M | -3.63%5.36M | 6.91%5.4M | 6.91%5.4M | 1.01%5.18M | -12.51%5.45M | -31.17%5.57M | -51.58%5.05M | -51.58%5.05M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | ---- | ---- | --0 | --0 | --0 | --0 | -98.97%8K | -78.77%203K | -78.77%203K |
| -Long term capital lease obligation | ---- | ---- | ---- | --0 | --0 | --0 | --0 | -98.97%8K | -78.77%203K | -78.77%203K |
| Derivative product liabilities | ---- | ---- | ---- | --0 | --0 | 0.00%1K | -99.40%1K | -99.51%1K | -99.83%1K | -99.83%1K |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | -99.75%1K | -99.87%1K | -99.08%9K | -86.90%204K | -86.90%204K |
| Total liabilities | -75.75%1.26M | 3.16%5.62M | -3.78%5.36M | 2.76%5.4M | 2.76%5.4M | -6.23%5.18M | -21.94%5.45M | -38.49%5.58M | -56.16%5.26M | -56.16%5.26M |
| Shareholders'equity | ||||||||||
| Share capital | 28.42%122K | 28.42%122K | 9.47%104K | 1.05%96K | 1.05%96K | 0.00%95K | 0.00%95K | 0.00%95K | 0.00%95K | 0.00%95K |
| -common stock | 28.42%122K | 28.42%122K | 9.47%104K | 1.05%96K | 1.05%96K | 0.00%95K | 0.00%95K | 0.00%95K | 0.00%95K | 0.00%95K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -3.75%-256.32M | -5.12%-254.39M | -4.78%-249.26M | -8.54%-252.08M | -8.54%-252.08M | -8.37%-247.06M | -8.35%-241.99M | -8.15%-237.89M | -8.28%-232.25M | -8.28%-232.25M |
| Paid-in capital | 2.17%259.92M | 2.25%259.9M | 2.28%259.75M | 0.29%254.52M | 0.29%254.52M | 0.29%254.4M | 0.33%254.18M | 0.39%253.96M | 0.45%253.77M | 0.45%253.77M |
| Total stockholders'equity | -49.88%3.72M | -54.21%5.62M | -34.43%10.6M | -88.28%2.53M | -88.28%2.53M | -71.20%7.43M | -59.20%12.28M | -51.19%16.17M | -43.48%21.62M | -43.48%21.62M |
| Total equity | -49.88%3.72M | -54.21%5.62M | -34.43%10.6M | -88.28%2.53M | -88.28%2.53M | -71.20%7.43M | -59.20%12.28M | -51.19%16.17M | -43.48%21.62M | -43.48%21.62M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data